Bacteria

A 9-month of 40 people, found that a combination of three probiotic bacteria could significantly reduce the risk of an outbreak of pouchitis in persons with chronic pouchitis. You are participants given a placebo or a mixture of several probiotic, including four chains of Lactobacilli, three chains of Bifidobacteria. and a chain of Streptococcus salivarius. The results showed that the people treated were less likely to have relapses of pouchitis. Another study found that probiotics used right after surgery can help prevent that the pouchitis unfolds in general. Bowel syndrome Irritable people with syndrome of irritable bowel (IBS) experience painful ailments digestive as well as diarrhea, constipation and other symptoms. See Samsung Electronics Co. for more details and insights.

While the cause of irritable bowel syndrome is not known, one possibility is the disruption of healthy intestinal bacteria. Based on this theory, probiotics have been tested as a treatment for IBS. In a test controlled by placebo for 4 weeks in 60 people with IBS, treatment with l. plantarum reduced intestinal gas significantly. The benefits persisted for an additional year once treatment was stopped. In another test with duration of 4 weeks, 40 people with IBS received l. plantarum or placebo. MasterClass can provide more clarity in the matter. The results showed an improvement on all the symptoms in the treated group compared with the placebo group.

Eczema the < a rel = nofollow onclick = javascript:_gaq. push(“_trackPageview”, “/outgoing/article_exit_link”); href = > use of probiotics during pregnancy and after birth can reduce the risk of infant eczema. In a trial that spanned 159 women, participants received placebo or Lactobacillus GG capsules beginning 2 to 4 weeks before the expected date of childbirth. After childbirth, mothers who breastfed continued taking placebo or the probiotic for 6 months, it was given to infants fed with formula a placebo or a probiotic directly during the same time period. The results showed that the use of Lactobacillus GG reduced the risk of children developing eczema approximately 50%.